COmparison of the Effect of Treatment With NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of StrUctural Damage in the Spine Over Two Years in Patients With ankyLosing Spondylitis: a Randomized Controlled Multicentre Trial
Phase of Trial: Phase IV
Latest Information Update: 20 Mar 2017
At a glance
- Drugs Celecoxib (Primary) ; Golimumab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Acronyms CONSUL
- 15 Sep 2016 Planned End Date changed from 1 Feb 2020 to 1 Jan 2020.
- 15 Sep 2016 Planned primary completion date changed from 1 Feb 2020 to 1 Jan 2020.
- 18 Aug 2016 Status changed from not yet recruiting to recruiting.